SHR.F344-(D12Mgh5-D12Mgh6)/Snk |
platelet intracellular calcium level |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
platelet calcium amount |
not specified |
105 days
| 10 |
48.0 |
nmol/l |
2.53 |
8.0 |
Fura-2 intracellular calcium assay |
0 |
0 |
|
64975 |
301 |
SHR.F344-(D12Mgh5-D12Mgh6)/Snk |
percentage of full platelet aggregation generated by thrombin |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
platelet aggregation trait |
not specified |
105 days
| 10 |
51.0 |
% |
9.49 |
30.0 |
light transmission aggregometry |
0 |
0 |
percentage of full platelet aggregation generated by thrombin (CMO:0003682) |
64981 |
301 |
SHR.F344-(D12Mgh5-D12Mgh6)/Snk |
systolic blood pressure |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
arterial blood pressure trait |
not specified |
105 days
| 10 |
166.0 |
mmHg |
2.53 |
8.0 |
tail cuff plethysmography |
0 |
0 |
|
64883 |
301 |
F344/Snk |
percentage of full platelet aggregation generated by thrombin |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
platelet aggregation trait |
not specified |
105 days
| 16 |
17.0 |
% |
3.25 |
13.0 |
light transmission aggregometry |
0.0 |
0 |
percentage of full platelet aggregation generated by thrombin (CMO:0003682) |
64980 |
301 |
SHR.F344-(D12Mgh5-D12Mgh6)/Snk |
heart weight to body weight ratio |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
heart mass |
not specified |
105 days
| 10 |
3.64 |
g/kg |
0.03 |
0.11 |
post excision weight measurement |
0 |
0 |
|
64880 |
301 |
F344/Snk |
systolic blood pressure |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
arterial blood pressure trait |
not specified |
105 days
| 16 |
136.0 |
mmHg |
1.25 |
5.0 |
tail cuff plethysmography |
0.0 |
0 |
|
64881 |
301 |
SHR/Snk |
platelet intracellular calcium level |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
platelet calcium amount |
not specified |
105 days
| 15 |
42.0 |
nmol/l |
2.07 |
8.0 |
Fura-2 intracellular calcium assay |
0 |
0 |
|
64974 |
301 |
F344/Snk |
platelet intracellular calcium level |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
platelet calcium amount |
not specified |
105 days
| 16 |
42.0 |
nmol/l |
1.75 |
7.0 |
Fura-2 intracellular calcium assay |
0 |
0 |
|
64976 |
301 |
SHR/Snk |
systolic blood pressure |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
arterial blood pressure trait |
not specified |
105 days
| 15 |
177.0 |
mmHg |
1.03 |
4.0 |
tail cuff plethysmography |
0.0 |
0 |
|
64882 |
301 |
SHR/Snk |
percentage of full platelet aggregation generated by thrombin |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
platelet aggregation trait |
not specified |
105 days
| 15 |
86.0 |
% |
2.07 |
8.0 |
light transmission aggregometry |
0.0 |
0 |
percentage of full platelet aggregation generated by thrombin (CMO:0003682) |
64982 |
301 |
SHR/Snk |
heart weight to body weight ratio |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
heart mass |
not specified |
105 days
| 15 |
4.35 |
g/kg |
0.08 |
0.3 |
post excision weight measurement |
0.0 |
0 |
|
12723 |
301 |
F344/Snk |
heart weight to body weight ratio |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
heart mass |
not specified |
105 days
| 16 |
2.82 |
g/kg |
0.1 |
0.38 |
post excision weight measurement |
0.0 |
0 |
|
12724 |
301 |